Actively Recruiting
Effects of Resistance Exercise on Blood Glucose in Post-menopausal Women With Type 1 Diabetes
Led by University of Alberta · Updated on 2025-07-08
16
Participants Needed
1
Research Sites
230 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Regular physical activity has substantial health benefits in people with type 1 diabetes. The fear of hypoglycemia, both during and after exercise, is a major barrier to exercise in this population. A major obstacle to providing specific physical activity and exercise advice is that there are still significant gaps in the fundamental understanding of the impact of physical activity and exercise on blood glucose levels in type 1 diabetes. Women with type 1 diabetes have a substantial increase in cardiovascular risk once they have passed menopause. They may lose both bone quality and muscle mass at a faster rate with aging than those without diabetes. Overall, these changes greatly increase the risk of both cardiovascular and frailty related complications. Despite the many potential benefits of resistance exercise for post-menopausal women with type 1 diabetes, there are currently no published studies examining the effects of resistance exercise in this population. Before being able to design a clinical trial of resistance exercise, an examination of the acute effects of resistance exercise on blood glucose levels in post-menopausal women with type 1 diabetes is required. The present study will compare the glycemic effects of a low resistance, high repetition (3 sets of 15 to 20 repetitions) weight lifting program to the effects of a moderate resistance, moderate repetition (3 sets of 8 to 10 repetitions). The investigators hypothesize that the high repetition program will be associated with a bigger decline in blood glucose during exercise, but that the moderate resistance program will be associated with a higher risk of post-exercise hypoglycemia.
CONDITIONS
Official Title
Effects of Resistance Exercise on Blood Glucose in Post-menopausal Women With Type 1 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female
- Diagnosed with type 1 diabetes for at least 1 year
- At least 12 months since last menstrual period
- Physically able and willing to perform resistance exercise
- HbA1c less than 10%
- Residing near Edmonton, Alberta and able to attend laboratory sessions at the University of Alberta
You will not qualify if you...
- HbA1c greater than 9.9%
- Frequent and unpredictable hypoglycemia
- Change in insulin management within 2 months before the study
- Blood pressure over 144/95
- Severe peripheral neuropathy
- History of cardiovascular disease
- Musculoskeletal injuries affecting resistance exercise ability
- Use of medications (other than insulin) that affect glucose metabolism
- Body mass index over 30 kg/m2
- Smoking
- Moderate to high alcohol intake (more than 2 drinks per day)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Alberta Diabetes Institute
Edmonton, Alberta, Canada, T6G 2R3
Actively Recruiting
Research Team
J
Jane Yardley, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here